These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Repression of IGF-I-induced osteoblast migration by (-)-epigallocatechin gallate through p44/p42 MAP kinase signaling. Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Otsuka T; Kozawa O Biomed Rep; 2018 Oct; 9(4):318-326. PubMed ID: 30233784 [TBL] [Abstract][Full Text] [Related]
6. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells. Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413 [TBL] [Abstract][Full Text] [Related]
7. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase. Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238 [TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C. Miwa M; Kozawa O; Tokuda H; Uematsu T Endocrinology; 1999 Nov; 140(11):5120-5. PubMed ID: 10537140 [TBL] [Abstract][Full Text] [Related]